ClinVar Genomic variation as it relates to human health
NM_006172.4(NPPA):c.190A>C (p.Ser64Arg)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006172.4(NPPA):c.190A>C (p.Ser64Arg)
Variation ID: 126847 Accession: VCV000126847.30
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1p36.22 1: 11847373 (GRCh38) [ NCBI UCSC ] 1: 11907430 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 19, 2014 Oct 8, 2024 Jan 18, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006172.4:c.190A>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006163.1:p.Ser64Arg missense NC_000001.11:g.11847373T>G NC_000001.10:g.11907430T>G NG_012926.1:g.5411A>C NG_065183.1:g.655T>G LRG_751:g.5411A>C LRG_751t1:c.190A>C - Protein change
- S64R
- Other names
- -
- Canonical SPDI
- NC_000001.11:11847372:T:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00060 (G)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 0.00060
1000 Genomes Project 30x 0.00062
Trans-Omics for Precision Medicine (TOPMed) 0.00164
The Genome Aggregation Database (gnomAD) 0.00165
Exome Aggregation Consortium (ExAC) 0.00191
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00200
The Genome Aggregation Database (gnomAD), exomes 0.00202
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
LOC114827827 | - | - | - | GRCh38 | - | 163 |
NPPA | - | - |
GRCh38 GRCh37 |
- | 210 | |
NPPA-AS1 | - | - | - | GRCh38 | - | 156 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Benign (2) |
criteria provided, single submitter
|
Jan 18, 2024 | RCV000114741.16 | |
Likely benign (4) |
criteria provided, single submitter
|
- | RCV000857935.11 | |
Benign (2) |
criteria provided, single submitter
|
Dec 15, 2021 | RCV000780554.6 | |
Likely benign (1) |
criteria provided, single submitter
|
May 16, 2022 | RCV002498490.1 | |
NPPA-related disorder
|
Likely benign (1) |
no assertion criteria provided
|
May 3, 2024 | RCV004755775.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Dec 15, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV000917915.3
First in ClinVar: Jun 02, 2019 Last updated: Jan 08, 2022 |
Comment:
Variant summary: NPPA c.190A>C (p.Ser64Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign … (more)
Variant summary: NPPA c.190A>C (p.Ser64Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 263016 control chromosomes, predominantly at a frequency of 0.0029 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 92.8 fold of the estimated maximal expected allele frequency for a pathogenic variant in NPPA causing Atrial Fibrillation phenotype (3.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.190A>C has been reported in the literature in multiple individuals affected with Atrial Fibrillation and Arrythmia, but also in healthy controls (example: Abraham_2010, Ritchie_2012, Disertori_2012, Disertori_2016, Hertz_2014, Hertz_2016, Guelly_2020). Co-occurrences with other pathogenic variants have been reported (SCN5A c.361C>T / p.Arg121Trp, Hertz_2014; KCNH2 c.2587C>T / p.Arg863X, internal sample), providing supporting evidence for a benign role. At least one publication reports experimental evidence evaluating an impact on protein function, reporting an increased potassium current associated with this variant (Abraham_2010). However, a case-control study reported that the variant was relatively common among non-AF controls, which suggested that it may not be causative i.e. the monogenic cause of AF, though it might be associated with very low penetrance or contribute in some as yet undefined fashion to AF susceptibility (Weeke_2015). Two ClinVar submitters have assessed this variant since 2014: one classified the variant as likely benign and the other as benign. Based on the evidence outlined above, the variant was classified as benign. (less)
|
|
Benign
(Jan 18, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Atrial fibrillation, familial, 6
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000289138.10
First in ClinVar: Jul 01, 2016 Last updated: Feb 14, 2024 |
|
|
Likely benign
(May 16, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Atrial fibrillation, familial, 6
Atrial standstill 2
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002808950.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Likely benign
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005256905.1
First in ClinVar: Sep 29, 2024 Last updated: Sep 29, 2024 |
|
|
Pathogenic
(Jan 01, 2010)
|
no assertion criteria provided
Method: literature only
|
ATRIAL FIBRILLATION, FAMILIAL, 6
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000148624.1
First in ClinVar: Apr 19, 2014 Last updated: Apr 19, 2014 |
Comment on evidence:
In affected members of a Caucasian kindred segregating autosomal dominant early-onset lone atrial fibrillation (ATFB6; 602201), Abraham et al. (2010) identified heterozygosity for a c.190A-C … (more)
In affected members of a Caucasian kindred segregating autosomal dominant early-onset lone atrial fibrillation (ATFB6; 602201), Abraham et al. (2010) identified heterozygosity for a c.190A-C transversion in exon 2 of the NPPA gene, resulting in a ser64-to-arg (S64R) substitution at a conserved residue in the proANP peptide. The missense mutation segregated with disease in the family and was not found in Caucasian, Han Chinese, Asian, or African American population controls. Abraham et al. (2010) noted that ANP levels were not significantly different between family members with AF who were mutations carriers and those who were unaffected and did not carry the mutation. Functional analysis in CHO cells demonstrated that coexpression of mutant NPPA with its ancillary subunit KCNE1 (176261) generated a significantly larger current compared to wildtype, which also activated earlier than wildtype currents. The mutant accelerated both activation and deactivation over all voltages. Pretreatment with anantin, a competitive ANP receptor antagonist, completely eliminated current augmentation and acceleration seen with the mutant, indicating that the effect of the S64R fragment on current is mediated by the endogenous ANP receptor. (less)
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001972785.1 First in ClinVar: Oct 07, 2021 Last updated: Oct 07, 2021 |
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001979887.1 First in ClinVar: Oct 16, 2021 Last updated: Oct 16, 2021 |
|
|
Likely benign
(May 03, 2024)
|
no assertion criteria provided
Method: clinical testing
|
NPPA-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005344996.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001931165.1 First in ClinVar: Sep 24, 2021 Last updated: Sep 24, 2021 |
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Clinical Genetics, Academic Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001978950.1 First in ClinVar: Oct 16, 2021 Last updated: Oct 16, 2021 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes. | Guelly C | PeerJ | 2021 | PMID: 33552729 |
Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart. | Hertz CL | International journal of legal medicine | 2016 | PMID: 26383259 |
Atrial fibrillation and NPPA gene p.S64R mutation: are cardiologists helpless spectators of healthy mutation carriers? | Disertori M | Journal of cardiovascular medicine (Hagerstown, Md.) | 2016 | PMID: 26200358 |
Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases. | Hertz CL | International journal of legal medicine | 2015 | PMID: 25467552 |
Examining rare and low-frequency genetic variants previously associated with lone or familial forms of atrial fibrillation in an electronic medical record system: a cautionary note. | Weeke P | Circulation. Cardiovascular genetics | 2015 | PMID: 25410959 |
Atrial fibrillation: the role of common and rare genetic variants. | Olesen MS | European journal of human genetics : EJHG | 2014 | PMID: 23838598 |
Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. | Disertori M | Circulation. Cardiovascular genetics | 2013 | PMID: 23275345 |
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. | Ritchie MD | Journal of the American College of Cardiology | 2012 | PMID: 22818067 |
Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. | Abraham RL | Journal of molecular and cellular cardiology | 2010 | PMID: 19646991 |
Text-mined citations for rs61757261 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.